Literature DB >> 29044608

Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.

Ming Lu1,2,3, Changhong Li1,2.   

Abstract

Pancreatic beta cells sense changes in nutrients during the cycles of fasting and feeding and release insulin accordingly to maintain glucose homeostasis. Abnormal beta cell nutrient sensing resulting from gene mutations leads to hypoglycemia or diabetes. Glucokinase (GCK) plays a key role in beta cell glucose sensing. As one form of congenital hyperinsulinism (CHI), activating mutations of GCK result in a decreased threshold for glucose-stimulated insulin secretion and hypoglycemia. In contrast, inactivating mutations of GCK result in diabetes, including a mild form (MODY2) and a severe form (permanent neonatal diabetes mellitus (PNDM)). Mutations of beta cell ion channels involved in insulin secretion regulation also alter glucose sensing. Activating or inactivating mutations of ATP-dependent potassium (KATP ) channel genes result in severe but completely opposite clinical phenotypes, including PNDM and CHI. Mutations of the other ion channels, including voltage-gated potassium channels (Kv 7.1) and voltage-gated calcium channels, also lead to abnormal glucose sensing and CHI. Furthermore, amino acids can stimulate insulin secretion in a glucose-independent manner in some forms of CHI, including activating mutations of the glutamate dehydrogenase gene, HDAH deficiency, and inactivating mutations of KATP channel genes. These genetic defects have provided insight into a better understanding of the complicated nature of beta cell fuel-sensing mechanisms.
© 2017 New York Academy of Sciences.

Entities:  

Keywords:  beta cell; congenital hyperinsulinism; insulin secretion; monogenic diabetes

Mesh:

Substances:

Year:  2017        PMID: 29044608      PMCID: PMC5788728          DOI: 10.1111/nyas.13448

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  145 in total

1.  Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.

Authors:  S S Fajans; J C Floyd; C A Thiffault; R F Knopf; T S Harrison; J W Conn
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

2.  The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.

Authors:  Qianghua Xia; Alessandra Chesi; Elisabetta Manduchi; Brian T Johnston; Sumei Lu; Michelle E Leonard; Ursula W Parlin; Eric F Rappaport; Peng Huang; Andrew D Wells; Gerd A Blobel; Matthew E Johnson; Struan F A Grant
Journal:  Diabetologia       Date:  2016-08-18       Impact factor: 10.122

3.  KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Authors:  Anna L Gloyn; Catherine Diatloff-Zito; Emma L Edghill; Christine Bellanné-Chantelot; Sylvie Nivot; Régis Coutant; Sian Ellard; Andrew T Hattersley; Jean Jacques Robert
Journal:  Eur J Hum Genet       Date:  2006-05-03       Impact factor: 4.246

4.  Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by K(ATP) channel mutations.

Authors:  Shannon H Fourtner; Charles A Stanley; Andrea Kelly
Journal:  J Pediatr       Date:  2006-07       Impact factor: 4.406

5.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

6.  Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency.

Authors:  Sunnie Yan-Wai Wong; Lesa J Beamer; Therese Gadomski; Tomas Honzik; Miski Mohamed; Saskia B Wortmann; Katja S Brocke Holmefjord; Marit Mork; Francis Bowling; Jolanta Sykut-Cegielska; Dieter Koch; Amanda Ackermann; Charles A Stanley; Daisy Rymen; Avraham Zeharia; Moeen Al-Sayed; Thomas Marquardt; Jaak Jaeken; Dirk Lefeber; Donald F Conrad; Tamas Kozicz; Eva Morava
Journal:  J Pediatr       Date:  2016-05-17       Impact factor: 4.406

7.  Why expression of some genes is disallowed in beta-cells.

Authors:  Roel Quintens; Nico Hendrickx; Katleen Lemaire; Frans Schuit
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

8.  L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase.

Authors:  A Sener; W J Malaisse
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

9.  System-L amino acid transporters play a key role in pancreatic β-cell signalling and function.

Authors:  Qi Cheng; Violeta D Beltran; Stanley M H Chan; Jeremy R Brown; Alan Bevington; Terence P Herbert
Journal:  J Mol Endocrinol       Date:  2015-12-08       Impact factor: 5.098

10.  Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels.

Authors:  T C Becker; H BeltrandelRio; R J Noel; J H Johnson; C B Newgard
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

View more
  4 in total

1.  Mechanisms of octanoic acid potentiation of insulin secretion in isolated islets.

Authors:  Tingting Zhang; Pan Chen; Charles A Stanley; Toshinori Hoshi; Changhong Li
Journal:  Islets       Date:  2019-03-08       Impact factor: 2.694

2.  Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells.

Authors:  John T Walker; Rachana Haliyur; Heather A Nelson; Matthew Ishahak; Gregory Poffenberger; Radhika Aramandla; Conrad Reihsmann; Joseph R Luchsinger; Diane C Saunders; Peng Wang; Adolfo Garcia-Ocaña; Rita Bottino; Ashutosh Agarwal; Alvin C Powers; Marcela Brissova
Journal:  JCI Insight       Date:  2020-05-21

Review 3.  Factors Influencing Mitochondrial Function as a Key Mediator of Glucose-Induced Insulin Release: Highlighting Nicotinamide Nucleotide Transhydrogenase.

Authors:  Zahra Aghelan; Sara Kiani; Abolfazl Nasiri; Masoud Sadeghi; Alireza Farrokhi; Reza Khodarahmi
Journal:  Int J Mol Cell Med       Date:  2020-08-10

4.  MODY2 in Asia: analysis of GCK mutations and clinical characteristics.

Authors:  Yuan Zhou; ShengNan Wang; Jing Wu; JianJun Dong; Lin Liao
Journal:  Endocr Connect       Date:  2020-05       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.